Evaluation of Cost of Nosocomial Infection
ECONI
2 other identifiers
observational
123
1 country
2
Brief Summary
This study will investigate the cost and impact of Healthcare Associated Infection (HAI) to patients, the health service and the wider community. This is in order to develop a model to allow policy makers to compare the cost effectiveness of Infection Prevention and Control measures in NHSScotland. The model will support policy makers and clinical teams in building a patient centred, safe, effective and efficient service.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2017
CompletedFirst Posted
Study publicly available on registry
August 18, 2017
CompletedStudy Start
First participant enrolled
June 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2020
CompletedFebruary 6, 2020
January 1, 2020
1.1 years
February 24, 2017
February 4, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Acquisition of healthcare associated infection
Number of patients who develop new HAI Defined using ECDC HAI case definitions, and including costs of care in hospital, post discharge and impact of usual activity, ability to work and social care.
During hospital stay, within one year post discharge for two hospital sites
Length of stay in hospital
Date of admission to discharge
All patient stays during the study year
Healthcare utilisation
Includes, specialty, antibiotic use, operations, post discharge health visits, community prescribing, out patient clinic attendance, re-admission to hospital
One year post discharge from hospital visit when recruited
Quality of Life
Quality of life will be measured using SF-12 and EQ-5D validated questionnaires
Utility score during hospital stay for HAI and non_HAI patients during hospital stay, one month post discharge and three months post discharge
Study Arms (2)
Patients with HAI during hospital stay
Patients who meet the European Centre for Disease Control (ECDC) Healthcare Associated Infection (HAI) case definitions. Case note review will be undertaken during hospital stay. Questionnaire will be administered at recruitment, pre-discharge, one, three, six and twelve months post discharge.
Patients without HAI during hospital stay
Patients who do not meet the European Centre for Disease Control (ECDC) Healthcare Associated Infection (HAI) case definitions. Case note review will be undertaken during hospital stay. Questionnaire will be administered at recruitment, pre-discharge, one, three, six and twelve months post discharge.
Interventions
Eligibility Criteria
Adult patients admitted to study hospitals over night during a one year study period
You may qualify if:
- Admitted to hospital for an overnight stay at study hospital
- Subjects capable of giving informed consent, or if appropriate, subjects having an acceptable individual capable of giving consent on the subject's behalf
- Any sex
- years old and over
- Patients without HAI will not be re-recruited into the study. Patients who have HAI on a subsequent admission will not be re-recruited but will be asked to complete a baseline data collection form (see below for discussion) NOTE: we do need to ensure this is clear within the ethics application.
- Good English language skills (sufficient to read and understand the participant information sheet without help)
You may not qualify if:
- Admitted to hospital as a day case
- Admitted to Hospitals other than the study hospitals
- Under 18 years
- Admitted to the study hospital during the study period and recruited to the study during a previous stay. See below
- Subjects not capable of giving informed consent unless legal representative or relative can provide proxy consent
- Patients who do not have English language skills to read and understand the information sheet without help
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Glasgow Caledonian Universitylead
- University of Strathclydecollaborator
- Nick Graves Independent Consultantcollaborator
- NHS Lothiancollaborator
- NHS Lanarkshirecollaborator
Study Sites (2)
Hairmyres Hospital
East Kilbride, United Kingdom
Edinburgh Royal Infirmary
Edinburgh, United Kingdom
Related Publications (1)
Stewart S, Robertson C, Manoukian S, Haahr L, Mason H, McFarland A, Dancer S, Cook B, Reilly J, Graves N; ECONI Steering Committee. How do we evaluate the cost of nosocomial infection? The ECONI protocol: an incidence study with nested case-control evaluating cost and quality of life. BMJ Open. 2019 Jun 19;9(6):e026687. doi: 10.1136/bmjopen-2018-026687.
PMID: 31221878DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jacqui M Reilly, PhD
Glasgow Caledonian University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2017
First Posted
August 18, 2017
Study Start
June 1, 2018
Primary Completion
June 30, 2019
Study Completion
January 31, 2020
Last Updated
February 6, 2020
Record last verified: 2020-01